Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy

Network-based approach to identify biomarkers predicting response and prognosis for HER2-negative breast cancer treatment with taxane-anthracycline neoadjuvant chemotherapy

Objective This study aims to identify effective gene networks and biomarkers to predict response and prognosis for HER2-negative breast cancer patients who received sequential taxane-anthracycline neoadjuvant chemotherapy. Materials and Methods Transcriptome data of training dataset including 310 HE...

Full description

Bibliographic Details
Main Authors: Cui Jiang, Shuo Wu, Lei Jiang, Zhichao Gao, Xiaorui Li, Yangyang Duan, Na Li, Tao Sun
Format: Article
Language:English
Published: PeerJ Inc. 2019-09-01
Series:PeerJ
Subjects:
Response
Breast cancer
Neoadjuvant chemotherapy
Prognosis
WGCNA
Online Access:https://peerj.com/articles/7515.pdf

Internet

https://peerj.com/articles/7515.pdf

Similar Items